Astrogen Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$9.6M
- Investors
-
19
Astrogen General Information
Description
Operator of a clinical and research-oriented biotech company intended to help in drug development for intractable neurological diseases. The company's drug development is performed through clinician-led clinical research and collaboration among clinicians, medicinal chemists, nurses, pharmacists, and caregivers, enabling medical professionals to develop treatments with improved efficacy, safety, ease of administration, and patentability.
Contact Information
Website
www.astrogen.co.krCorporate Office
- 440, Hyuksin-Daero
- Dong
- Daegu, Gyeongsang
- South Korea
Corporate Office
- 440, Hyuksin-Daero
- Dong
- Daegu, Gyeongsang
- South Korea
Astrogen Timeline
Astrogen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series C) | 15-Jan-2024 | $9.6M | Completed | Clinical Trials - Phase 3 | ||
| 5. Accelerator/Incubator | 23-Oct-2023 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC (Series B) | 23-Jan-2022 | Completed | Clinical Trials - Phase 2 | |||
| 3. Early Stage VC (Series B) | 14-Dec-2020 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series A) | 01-Aug-2019 | $4.24M | $5.93M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 01-Aug-2018 | $1.69M | $1.69M | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Astrogen Patents
Astrogen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026014835-A1 | Liposome formulation of l-serine and method for preparing same | Pending | 12-Jul-2024 | ||
| US-12606518-B2 | Crystalline form of l-serine and process of preparing same | Active | 10-Jul-2024 | ||
| US-20260015312-A1 | New crystalline form of l-serine and process of preparing same | Active | 10-Jul-2024 | ||
| WO-2026014573-A1 | Novel crystal form of l-serine and method for preparing same | Pending | 10-Jul-2024 | ||
| EP-4831163-A1 | Improved method for preparation of (s)-biloxazine or salt thereof | Pending | 18-Dec-2023 | C07D265/30 |
Astrogen Signals
Astrogen Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| S&S Investment | Venture Capital | Minority | ||
| Xquared | Venture Capital | Minority | ||
| BiiG WAVE | Accelerator/Incubator | |||
| iM Investment Partners | Corporate Venture Capital | Minority | ||
| JCH Investment | Venture Capital | Minority |
Astrogen Investments (1)
Astrogen’s most recent deal was a Corporate Asset Purchase with Korea Land and Housing (Daegu-Gyeongbuk Advanced Medical Complex in Daegu, South Korea) for . The deal was made on 12-Jun-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Korea Land and Housing (Daegu-Gyeongbuk Advanced Medical Complex in Daegu, South Korea) | 12-Jun-2022 | Corporate Asset Purchase | Buildings and Property |
Astrogen FAQs
-
When was Astrogen founded?
Astrogen was founded in 2017.
-
Where is Astrogen headquartered?
Astrogen is headquartered in Daegu, South Korea.
-
What is the size of Astrogen?
Astrogen has 34 total employees.
-
What industry is Astrogen in?
Astrogen’s primary industry is Drug Discovery.
-
Is Astrogen a private or public company?
Astrogen is a Private company.
-
What is Astrogen’s current revenue?
The current revenue for Astrogen is .
-
How much funding has Astrogen raised over time?
Astrogen has raised $34.8M.
-
Who are Astrogen’s investors?
S&S Investment, Xquared, BiiG WAVE, iM Investment Partners, and JCH Investment are 5 of 19 investors who have invested in Astrogen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process